Juan Ma

Title: Juan Ma - Innovator in Cancer Immunotherapy

Introduction

Juan Ma is a prominent inventor based in Beijing, China. He has made significant contributions to the field of cancer immunotherapy through his innovative research and development efforts. His work focuses on creating advanced therapeutic solutions that target critical pathways in cancer treatment.

Latest Patents

Juan Ma holds a patent for a "Humanized anti-PD-1 antibody and the use thereof." This patent describes a recombinant humanized monoclonal antibody against programmed cell death receptor-1 (PD-1) or an antigen-binding fragment thereof. The invention can be utilized in tumor or cancer immunotherapy. Additionally, the patent provides nucleic acid sequences encoding the antibody or its antigen-binding fragment, vectors containing these nucleic acid sequences, pharmaceutical compositions, and kits.

Career Highlights

Juan Ma is associated with Sinocelltech Ltd., a company dedicated to advancing biopharmaceutical innovations. His role at the company has allowed him to contribute to groundbreaking research in the field of immunotherapy. His expertise and dedication have positioned him as a key player in the development of novel cancer treatments.

Collaborations

Juan Ma has collaborated with notable colleagues, including Liangzhi Xie and Chunyun Sun. These partnerships have fostered a collaborative environment that enhances the research and development process, leading to innovative solutions in cancer therapy.

Conclusion

Juan Ma's contributions to cancer immunotherapy through his patent and work at Sinocelltech Ltd. highlight his commitment to advancing medical science. His innovative approach and collaborative efforts continue to pave the way for new therapeutic options in the fight against cancer.